Arber, C., G. Baerlocher, Y. Chalandon, M. Daskalakis, M. Duchosal, M. Fehr, S. Gerull, T. Güngör, G. Nair, T. Pabst, J. R. Passweg, B. Piccolruaz, C. Renner, A. Ruefer, D. Schneidawind, G. Stüssi, S. Zeerleder, and J. P. Halter. “Technical Comment On: Trottmann M, Et Al. Real-World Expenditures and Survival Time After CAR-T Treatment for Large B-Cell Lymphoma in Switzerland: A Retrospective Study Using Insurance Claims Data”. Swiss Medical Weekly, vol. 154, no. 10, Oct. 2024, p. 3704, doi:10.57187/s.3704.